Accro will retain global rights to develop, manufacture, and commercialize AC-201 (excluding Chinese Mainland, Hong Kong SAR, and Macau SAR)
Merger is expected to streamline operations and provide unified management focus, driving efficiency and strategic alignment
The FDA also expanded Repatha’s use as monotherapy to include patients with homozygous familial hypercholesterolemia
This authorization follows FDA approval in June and WHO’s July recommendation adding twice-yearly lenacapavir as a PrEP option
The US generic market is crucial for Indian pharma, contributing about 35% to its total revenue, around US$ 10.7 billion
The inspection, conducted from June 23 to June 25, 2025, concluded with zero Form 483 observations
Merck will share two oral presentations on ASCVD treatment patterns and patient burden
The $700 million project is part of Roche’s $50 billion investment in US manufacturing, infrastructure and R&D
Dr. Reddy’s becomes the first pharmaceutical company to receive regulatory approval to launch Linaclotide in India under the brand name Colozo
Subscribe To Our Newsletter & Stay Updated
